Standard BioTools Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Operating Revenue	169.74	174.43	106.34	97.95	128.85	131.39
Other Revenue	-	-	-	-	1.73	6.76
Revenue	169.74	174.43	106.34	97.95	130.58	138.14
Revenue Growth (YoY)	79.77%	64.03%	8.57%	-24.99%	-5.47%	17.83%
Cost of Revenue	87.84	90.17	55.89	60.9	99.15	91.28
Gross Profit	81.9	84.26	50.45	37.05	31.43	46.87
Selling, General & Admin	165.39	156.61	87.54	102.29	98.89	97.9
Research & Development	58.64	62.41	25.95	33.86	-	-
Operating Expenses	224.03	219.02	113.49	136.14	98.89	97.9
Operating Income	-142.13	-134.76	-63.04	-99.09	-67.46	-51.04
Interest Expense	-0.59	-3.32	-4.57	-4.33	-3.82	-3.57
Interest & Investment Income	11.41	20.2	5.57	2.23	-	-
Other Non Operating Income (Expenses)	-4.27	-5.17	1.39	-60.9	7.62	0.51
EBT Excluding Unusual Items	-135.58	-123.05	-60.64	-162.09	-63.66	-54.1
Merger & Restructuring Charges	-17.31	-40.48	-13.56	-13.59	-	-
Asset Writedown	-	-	-	-3.53	-	-
Other Unusual Items	3.4	25.21	-	-13.72	-	-
Pretax Income	-149.49	-138.31	-74.2	-192.93	-63.66	-54.1
Income Tax Expense	-1.64	0.57	0.45	-2.83	-4.42	-1.08
Net Income	-128.25	-138.89	-74.66	-190.1	-59.24	-53.02
Preferred Dividends & Other Adjustments	-	46.01	-	-	-	-
Net Income to Common	-128.25	-184.9	-74.66	-190.1	-59.24	-53.02
Shares Outstanding (Basic)	379	353	79	78	76	72
Shares Outstanding (Diluted)	379	353	79	78	76	72
Shares Change (YoY)	35.61%	346.24%	1.09%	3.32%	5.19%	7.88%
EPS (Basic)	-0.34	-0.52	-0.94	-2.43	-0.78	-0.74
EPS (Diluted)	-0.34	-0.52	-0.94	-2.43	-0.78	-0.74
Free Cash Flow	-98.42	-151.81	-46.12	-93.2	-57.33	-28.13
Free Cash Flow Per Share	-0.26	-0.43	-0.58	-1.19	-0.76	-0.39
Gross Margin	48.25%	48.31%	47.44%	37.83%	24.07%	33.92%
Operating Margin	-83.74%	-77.25%	-59.28%	-101.17%	-51.66%	-36.94%
Profit Margin	-75.56%	-106.00%	-70.20%	-194.08%	-45.36%	-38.38%
Free Cash Flow Margin	-57.98%	-87.03%	-43.37%	-95.15%	-43.90%	-20.37%
EBITDA	-123.95	-117.9	-47.86	-84.06	-63.81	-47.02
EBITDA Margin	-73.02%	-67.59%	-45.01%	-85.82%	-48.86%	-34.04%
D&A For EBITDA	18.18	16.86	15.18	15.03	3.65	4.01
EBIT	-142.13	-134.76	-63.04	-99.09	-67.46	-51.04
EBIT Margin	-83.74%	-77.25%	-59.28%	-101.17%	-51.66%	-36.94%
Revenue as Reported	169.74	174.43	106.34	97.95	130.58	138.14
Advertising Expenses	-	5.9	2	-	3.4	1.6

Updated Nov 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q